Aarti Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has informed the stock exchanges that its trading window will remain closed from October 1, 2025, until 48 hours after the declaration of financial results for the quarter and half year ended September 30, 2025. This is a mandatory compliance action under SEBI's Prohibition of Insider Trading Regulations, 2015. During this period, designated persons and their immediate relatives are prohibited from trading in the company's shares. The closure signals that the company is in a quiet period ahead of its Q2 and H1 FY26 earnings announcement.
This is a routine regulatory filing and has no direct impact on the stock price. It does, however, indicate that Q2 FY26 results are expected to be announced soon, which investors should watch for as it may influence near-term stock movement.